The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Deignan Charles A. since 2016.
This trader's CIK number is 1664690.
At the time of last reporting, Deignan Charles A. was the Chief Financial Officer of Clearside Biomedical, Inc.. (stock ticker symbol CLSD).
Also see all insider trading activities at Clearside Biomedical, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | CLSD | 0 | $0 | 12,900 | $16,512 | 0 | $0 |
| 2023 | CLSD | 0 | $0 | 14,030 | $21,045 | 34,090 | $13,636 |
| 2022 | CLSD | 0 | $0 | 8,833 | $18,460 | 23,636 | $9,454 |
| 2021 | CLSD | 0 | $0 | 5,738 | $30,787 | 0 | $0 |
| 2020 | CLSD | 0 | $0 | 14,992 | $28,184 | 0 | $0 |
| 2019 | CLSD | 17,500 | $22,150 | 0 | $0 | 0 | $0 |
| 2018 | CLSD | 500 | $5,895 | 0 | $0 | 0 | $0 |
| 2017 | CLSD | 1,000 | $7,065 | 0 | $0 | 0 | $0 |
| 2016 | CLSD | 0 | $0 | 2 | $14 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-01-19 | CLSD | Sale | 12,900 | 1.28 | 16,512 |
| 2023-09-13 | CLSD | Option Ex | 34,090 | .40 | 13,636 |
| 2023-01-19 | CLSD | Sale | 14,030 | 1.50 | 21,045 |
| 2022-12-20 | CLSD | Option Ex | 23,636 | .40 | 9,454 |
| 2022-01-19 | CLSD | Sale | 8,833 | 2.09 | 18,460 |
| 2021-09-21 | CLSD | Sale | 2,800 | 6.41 | 17,948 |
| 2021-06-21 | CLSD | Sale | 2,938 | 4.37 | 12,839 |
| 2020-06-01 | CLSD | Sale | 14,992 | 1.88 | 28,184 |
| 2019-11-12 | CLSD | Buy | 7,500 | 1.14 | 8,550 |
| 2019-03-15 | CLSD | Buy | 10,000 | 1.36 | 13,600 |
| 2018-03-23 | CLSD | Buy | 500 | 11.79 | 5,895 |
| 2017-08-14 | CLSD | Buy | 1,000 | 7.07 | 7,065 |
| 2016-06-07 | CLSD | Sale | 2 | 7.00 | 14 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Deignan Charles A. (Chief Financial Officer of Clearside Biomedical, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.